Trinity Bio ADR (TRIB) Stock Price, Quote & News

Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles,...

Industry: Medical Devices

Sector: Healthcare

Phone: 353 1 276 9800

Fax: 353 1 276 9888

Website: www.trinitybiotech.com

Address:

IDA Business Park, Bray, Ireland

kd1313 Aug. 23 at 6:29 AM

$TRIB I’ll have a $70 avg if this split happens.

0 · Reply

deepthinker Aug. 22 at 11:50 PM

$TRIB

0 · Reply

Michael73w Aug. 22 at 11:24 PM

$TRIB here’s the article where Google AI is picking it up from

1 · Reply

Think_Bigly Aug. 22 at 7:19 PM

$TRIB Pure BS

1 · Reply

Michael73w Aug. 22 at 7:04 PM

$TRIB what day will it start trading at the reverse split price? Can’t figure out if it’s Tuesday or Wednesday

1 · Reply

Think_Bigly Aug. 22 at 6:42 PM

$TRIB The rate signal cometh. Sell IMMCo

1 · Reply

MMillionaire Aug. 22 at 3:23 PM

$TRIB

0 · Reply

NeurNet Aug. 22 at 3:22 PM

$TRIB For the first time in several days... the three main US market indices are in the green! Some more or less good news must have come from Jackson Hole! DJ: 1.85%; Nasdaq 100: 1.8%!! And the seven 'magnificent seven' are ALL in the green again too. The torpor of the last few days that took TRIB into 100% unjustified falls also disappears, this is felt immediately!!

0 · Reply

J_Sorias_Conscience Aug. 22 at 3:20 PM

$TRIB https://www.adrbny.com/content/dam/adr/documents/corporate-actions-dr/files/AD2000217.pdf Looks legit to me but who knows.

2 · Reply

ChillOnMe Aug. 22 at 3:05 PM

$TRIB Anyone claiming there is an RS please just post the link to the SEC filing, otherwise it isn't happening.

0 · Reply

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

Aug 20, 2025, 9:00 AM EDT - 2 days ago

Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Aug 14, 2025, 9:00 AM EDT - 8 days ago

Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service

Aug 12, 2025, 8:45 AM EDT - 10 days ago

Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor

Aug 7, 2025, 8:00 AM EDT - 15 days ago

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

Jul 24, 2025, 8:20 AM EDT - 4 weeks ago

Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market

Jul 1, 2025, 9:00 AM EDT - 7 weeks ago

Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

Jun 24, 2025, 8:00 AM EDT - 2 months ago

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

May 15, 2025, 4:00 PM EDT - 3 months ago

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

Mar 14, 2025, 4:30 PM EDT - 5 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Mar 13, 2025, 7:30 AM EDT - 5 months ago

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Feb 28, 2025, 8:30 AM EST - 6 months ago

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology

Feb 6, 2025, 7:30 AM EST - 7 months ago

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

Jan 28, 2025, 7:20 AM EST - 7 months ago

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Dec 24, 2024, 8:33 AM EST - 8 months ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Dec 18, 2024, 11:00 AM EST - 8 months ago

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Nov 15, 2024, 12:37 PM EST - 10 months ago

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 9:00 AM EST - 10 months ago

Trinity Biotech Announces Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 10 months ago

Trinity Biotech to Announce Q3 2024 Financial Results

Nov 7, 2024, 8:19 AM EST - 10 months ago

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Oct 25, 2024, 8:45 AM EDT - 10 months ago

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Oct 25, 2024, 8:45 AM EDT - 10 months ago

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Oct 7, 2024, 8:15 AM EDT - 11 months ago

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Sep 24, 2024, 4:05 PM EDT - 11 months ago

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Sep 18, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Sep 9, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Sep 3, 2024, 9:55 AM EDT - 1 year ago

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Aug 26, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Aug 20, 2024, 5:00 PM EDT - 1 year ago

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Aug 16, 2024, 3:43 AM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Trinity Biotech Announces Q2 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech to Announce Q2 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Aug 2, 2024, 9:24 AM EDT - 1 year ago

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Jul 9, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Announces Appointment of A New CFO

Jun 24, 2024, 7:00 AM EDT - 1 year ago

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

Jun 10, 2024, 9:10 AM EDT - 1 year ago

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

Jun 3, 2024, 4:00 AM EDT - 1 year ago

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

May 23, 2024, 6:44 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript

May 23, 2024, 8:00 AM EDT - 1 year ago

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

May 21, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech plc to Announce Q1 2024 Financial Results

May 16, 2024, 9:18 AM EDT - 1 year ago

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

May 13, 2024, 11:42 AM EDT - 1 year ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

May 8, 2024, 10:36 AM EDT - 1 year ago

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

Apr 4, 2024, 3:03 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Mar 28, 2024, 6:39 PM EDT - 1 year ago

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Mar 8, 2024, 10:03 AM EST - 1 year ago

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Feb 15, 2024, 12:34 PM EST - 1 year ago

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Feb 13, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

kd1313 Aug. 23 at 6:29 AM

$TRIB I’ll have a $70 avg if this split happens.

0 · Reply

deepthinker Aug. 22 at 11:50 PM

$TRIB

0 · Reply

Michael73w Aug. 22 at 11:24 PM

$TRIB here’s the article where Google AI is picking it up from

1 · Reply

Think_Bigly Aug. 22 at 7:19 PM

$TRIB Pure BS

1 · Reply

Michael73w Aug. 22 at 7:04 PM

$TRIB what day will it start trading at the reverse split price? Can’t figure out if it’s Tuesday or Wednesday

1 · Reply

Think_Bigly Aug. 22 at 6:42 PM

$TRIB The rate signal cometh. Sell IMMCo

1 · Reply

MMillionaire Aug. 22 at 3:23 PM

$TRIB

0 · Reply

NeurNet Aug. 22 at 3:22 PM

0 · Reply

J_Sorias_Conscience Aug. 22 at 3:20 PM

$TRIB https://www.adrbny.com/content/dam/adr/documents/corporate-actions-dr/files/AD2000217.pdf Looks legit to me but who knows.

2 · Reply

ChillOnMe Aug. 22 at 3:05 PM

$TRIB Anyone claiming there is an RS please just post the link to the SEC filing, otherwise it isn't happening.

0 · Reply

kd1313 Aug. 22 at 2:58 PM

$TRIB so no r/s? That would be a devastating blow if they do.

0 · Reply

Clydagh Aug. 22 at 2:06 PM

$TRIB the only reaason for the flurry of nonsense PRs is to hype the stock over a $1 for 10 days. Gillard has done this before. as for an RS - this is Trib's ADR manager: https://www.adrbny.com/content/adr/us/en/directory/dr-details.896438504.html

1 · Reply

EDayTrade Aug. 22 at 12:48 PM

$TRIB Can we trust ChatGPT? No filing for stock split that I saw on SEC. GOV.

1 · Reply

TherealDave214 Aug. 22 at 12:44 PM

$TRIB this is your daily reminder that Google AI is not a reliable financial advisor and it does not vet its sources. go one layer deeper with your dd.

0 · Reply

TherealDave214 Aug. 22 at 12:38 PM

$TRIB Lets clear this up folks. there has NEVER been an RS scheduled for this August. the only mention of that anywhere came from an unknown chinese site with mo author or any evidence or proof. the company has not made ANY statements or announcements of an RS, nor have there been ANY filings. it was not retracted, it never existed.

2 · Reply

NeurNet Aug. 22 at 11:57 AM

$TRIB Re.. Yes... According to TipRanks: 'RSplit' scheduled for 08/27/25 According to Nasdaq: 'RSplit' not scheduled (anymore) (at the time of this post...lol)

0 · Reply

NeurNet Aug. 22 at 11:44 AM

$TRIB I'm correcting this... The reverse split date WAS, if I'm not mistaken, scheduled for August 26, 2025. Now, nothing's scheduled for that date... So there's a mistake... somewhere... lol...

0 · Reply

NeurNet Aug. 22 at 10:35 AM

$TRIB @MarilynStocks We will have counted 10 consecutive days of closing >=1, since 12-08-25, at the closing on Monday, 25-08-25. Trinity will therefore request, expressly, to cancel the Reverse Split scheduled for, yes, 26-08-25. They are keeping PRs for this 10-day period. "All this" with the aim of canceling the Reverse Split, I assume.

0 · Reply

MarilynStocks Aug. 22 at 6:34 AM

$TRIB reverse split Thursday. 1 for 5

0 · Reply

MTakla Aug. 21 at 5:34 PM

$TRIB so if we close above $1 today and tomorrow, then the threat of delisting is gone?

2 · Reply

ajmore Aug. 21 at 4:14 PM

$TRIB shorts closed 300k shares yesterday. 800k still short. What are the odds top good news on Friday! Bring in the 5 USD, the 10USD and the 25 USD. millionaire maker!

2 · Reply

jeandaniel13 Aug. 21 at 2:54 PM

$TRIB Paul Tivnan! Sure, something is cooking.

0 · Reply

Market Cap	28.16M
Revenue (ttm)	61.56M
Net Income (ttm)	-31.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-51.64%
Debt to Equity Ratio	-1.82

Volume	832,600
Avg Vol	6,424,514
Day's Range	N/A - N/A
Shares Out	18.05M
Stochastic %K	28%
Beta	0.77
Analysts	Hold
Price Target	$15.00